{"nct_id":"NCT02234986","title":"A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2015-10","start_date_type":null,"primary_completion_date":"2018-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2018-06-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CASI"]}